Deborah E Citrin

16PUBLICATIONS
129CO-AUTHORS
Molecular targetsRadiation therapyPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Natural language processing
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|May 25, 2026
Ablation of glypican-3 enhances radiosensitivity in liver cancer by prolonging G2/M arrest and activating the ATM/CHK2 pathway.

|Mar 04, 2026
Effects of Radiotherapy in Normal Tissue.

Deborah E Citrin, Robert D Timmerman

|Oct 23, 2025
National Cancer Institute's Working Group on Biochemically Recurrent Prostate Cancer: Clinical Trial Design Considerations.

David J Einstein, Melissa L Abel, Jeanny B Aragon-Ching

|Oct 02, 2025
Radiogenomic Profiling of Prostate Tumors prior to External Beam Radiotherapy Converges on a Transcriptomic Signature of TGF-β Activity Driving Tumor Recurrence.

Anson T Ku, Uma Shankavaram, Shana Y Trostel

|Aug 18, 2025
p53-miR-34a feedback in lung fibroblasts regulates antifibrotic effects of CSP7, nintedanib, and pirfenidone.

Liang Fan, Rashmi S Shetty, Huy Minh Dao

|Sep 03, 2024
Bladder-Preserving Trimodality Treatment for High-Grade T1 Bladder Cancer: Results From Phase II Protocol NRG Oncology/RTOG 0926.

Douglas M Dahl, Joseph P Rodgers, William U Shipley

Pageof 3

Frequent Collaborators

4 joint publications

Howard M Sandler

3 joint publications

Krishnan R Patel

3 joint publications

Peter L Choyke

3 joint publications

Jeff M Michalski